AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue

Navigation

Page 49 of 55

50 Treatment 11.2.1. Revascularization for ALI COR LOE Recommendations 1 A 1. In patients with ALI and a salvageable limb, revascularization (endovascular or surgical, including catheter-directed thrombolysis) is indicated to prevent amputation. 2a C-EO 2. In patients with ALI and a salvageable limb who are treated with catheter-directed thrombolysis, adjunctive revascularization (ie, endovascular, or surgical) procedures can be useful. 2b C-LD 3. In patients presenting with ALI from chemotherapeutic or prothrombotic viral states, it may be reasonable to take a more deliberate planning strateg y before engaging in a definitive revascularization or medical treatment plan. 3: Harm C-EO 4. In patients with ALI with a nonsalvageable limb, revascularization of nonviable tissue should not be performed. 11.2. Management of ALI 11.1. Initial Clinical Evaluation and Diagnostic Approach to ALI COR LOE Recommendations 1 C-EO 1. Patients with ALI should be evaluated on an emergency basis by a clinical with sufficient experience to assess limb viability and implement appropriate therapy. 1 C-LD 2. In patients with suspected ALI, the initial clinical evaluation should rapidly assess limb viability and potential for salvage and can be achieved without noninvasive imaging (ie, duplex ultrasound, CTA, or MRA). 2b C-EO 3. In patients with ALI who have a complicated history of revascularization procedures, it may be reasonable to obtain noninvasive imaging (ie, duplex ultrasound, CTA, or MRA) before deciding to proceed with revascularization. 11. Acute Limb Ischemia

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024